Cases of a new COVID-19 variant, temporarily designated JN.1, are rising rapidly nationwide. According to data from the U.S. Centers for Disease Control and Prevention, JN.1 now accounts for 44% of all COVID-19 infections in the country. That represents more than double its share compared to just a week prior, highlighting the dramatic growth rate […]
- Medical Billing
- Credentialing
- Payer Contracting
- Specialties
- Behavioral Health
- Toxicology
- Genetic Testing
- Pharmacogenetic (PGx) Testing
- COVID-19 Testing
- Allergy Testing
- Skilled Nursing Facilities
- Urgent Care
- Oncology
- Pathology
- OBGYN
- Biologics and Specialty Drugs
- Telestroke and Teleneurology
- Remote Patient Monitoring
- Speech Therapy
- Home Infusion Therapy
- DME
- Substance Abuse
- Sleep Study Labs
- Physical Therapy (PT)
- Occupational Therapy
- HL7 Integration
- RPA
- Blog
- Contact